Who invested in Alantos Pharmaceuticals?
Alantos Pharmaceuticals's investors include Earlybird Venture Capital, Ventech, SV Life Sciences, Oxford Bioscience Partners and ABN AMRO Fund, and 1 more on record.
United States · Series B startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2003, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Alantos Pharmaceuticals's investors include Earlybird Venture Capital, Ventech, SV Life Sciences, Oxford Bioscience Partners and ABN AMRO Fund, and 1 more on record.
Alantos Pharmaceuticals has raised $20M across 2 rounds since 2003. One round did not disclose an amount, so the total is a floor.
Alantos Pharmaceuticals's most recent round was a Series B of $20M in Mar 2005.
Its most recent round, $20M in Mar 2005, is also its largest on record.
Alantos Pharmaceuticals's first round on record, in Feb 2003, was backed by Earlybird Venture Capital.
Alantos Pharmaceuticals's latest named round is a Series B, in Mar 2005.
Alantos Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.